No Data
Tsudakoma: Confirmation letter.
Tsudakoma: Financial Report - 114th Term (2023/12/01 - 2024/11/30)
Tsudakoma: Extraordinary Report
Stocks that moved the previous day part 1 note, Cookleb, Kobe Bussan, ETC.
Stock name <code> Closing price on the 16th ⇒ Comparison with the previous day Welldis <2901> 765 +442 A dividend is expected for the fiscal year ending in March 2025. A part of the Shareholder benefit program has also been announced. Asakuma <7678> 4145 -175 The profit Financial Estimates for the fiscal year ending in January 2025 have been downwardly revised. Tsudakoma <6217> 430 +26 Operating profit converted to black from the previous term, estimated to be 2.2 times this term. Renascience <4889> 651 +100 Announced results of a clinical performance trial to validate an AI predicting insulin dosage for diabetic patients (速報).
Afternoon session [Active stocks and traded stocks]
*Weldish <2901> 765 + 4425 Fiscal Year 2023 dividend reinstatement. Shareholder benefit program partial change announced. *Asakuma <7678> 4145 -175 Fiscal Year 2025 profit Financial Estimates revised downward. *Tsudakoma Industries <6217> 430 +26 operating profit has turned positive from the previous period, expected to be 2.2 times this period. *Lenascience <4889> 651 +100 announced results of a clinical performance trial of AI predicting insulin dosages for diabetes patients (速報). *note <5243>
Tsudakoma: Summary of Financial Results for the Fiscal Year Ending Reiwa 6/11 [Japanese GAAP] (Consolidated)